Login

Library
Shopping Cart
Drug DB
Remember Me
Forgot password/Login issues?
loading animation for AJAX calls
 
 

Pharmaceuticals

Global Markets for Contract Pharmaceutical Manufacturing, Research And Packaging: Focus on Emerging Markets

Bookmark and Share

REPORT HIGHLIGHTS

  • The global pharmaceutical contract manufacturing and contract research organizations revenue reached at $196.5 billion in 2010, it will further grow to $217.9 billion in 2011 and is projected to reach at $360.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.6%.
  • The Rest of World (ROW) and emerging markets had revenue of approximately $10.5 billion in 2010, which increased to $11.2 billion in 2011 in the bulk drugs/API market. The revenue of this market is expected to rise to $15.5 billion in 2016, with the CAGR expected to rise at 6.7%.
  • The ROW market for contract manufacturers that produce solid dosage forms including tablets and capsules had revenue of $2.9 billion in 2010. The ROW market revenue for the solid dosage form is projected to reach $7 billion by the end of 2016 while increasing at a CAGR of 15.5%.

SUMMARY FIGURE
GLOBAL PHARMACEUTICAL CONTRACT MANUFACTURING AND CONTRACT RESEARCH ORGANIZATIONS REVENUE, 2009-2016
($ BILLIONS)
Source: BCC Research